NEPHROS INCNEPHEarnings & Financial Report
Nephros Inc is a medical technology company that develops and commercializes high-performance water purification systems, infection control products, and renal care solutions. Its offerings are primarily used by hospitals, dialysis clinics, and long-term care facilities across North America to reduce waterborne pathogen risks and improve patient outcomes.
NEPH Q4 FY2025 Key Financial Metrics
Revenue
$4.7M
Gross Profit
$2.8M
Operating Profit
$18.0K
Net Profit
$62.0K
Gross Margin
58.4%
Operating Margin
0.4%
Net Margin
1.3%
YoY Growth
22.2%
EPS
$0.01
NEPHROS INC Q4 FY2025 Financial Summary
NEPHROS INC reported revenue of $4.7M (up 22.2% YoY) for Q4 FY2025, with a net profit of $62.0K (down 82.2% YoY) (1.3% margin). Cost of goods sold was $2.0M, operating expenses totaled $2.7M.
Key Financial Metrics
| Total Revenue | $4.7M |
|---|---|
| Net Profit | $62.0K |
| Gross Margin | 58.4% |
| Operating Margin | 0.4% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
NEPHROS INC Q4 FY2025 revenue of $4.7M breaks down across 2 segments, led by Products at $4.6M (97.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $4.6M | 97.7% |
| Other | $108.0K | 2.3% |
NEPHROS INC Revenue by Segment — Quarterly Trend
NEPHROS INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $4.6M | $4.6M | $4.3M | $4.7M |
| Other | $108.0K | $168.0K | $108.0K | $171.0K |
NEPHROS INC Annual Revenue by Year
NEPHROS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $18.8M).
NEPHROS INC Quarterly Revenue & Net Profit History
NEPHROS INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $4.7M | +22.2% | $62.0K | 1.3% |
| Q3 FY2025 | $4.8M | +35.4% | $337.0K | 7.1% |
| Q2 FY2025 | $4.4M | +35.9% | $237.0K | 5.4% |
| Q1 FY2025 | $4.9M | +38.5% | $558.0K | 11.4% |
| Q4 FY2024 | $3.9M | +18.9% | $349.0K | 9.0% |
| Q3 FY2024 | $3.5M | -6.0% | $183.0K | 5.2% |
| Q2 FY2024 | $3.3M | -8.3% | $-289.0K | -8.9% |
| Q1 FY2024 | $3.5M | -4.7% | $-169.0K | -4.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5M | $3.3M | $3.5M | $3.9M | $4.9M | $4.4M | $4.8M | $4.7M |
| YoY Growth | -4.7% | -8.3% | -6.0% | 18.9% | 38.5% | 35.9% | 35.4% | 22.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $11.4M | $11.1M | $10.4M | $11.2M | $11.8M | $12.2M | $13.2M | $13.6M |
| Liabilities | $3.2M | $3.2M | $2.2M | $2.6M | $2.5M | $2.6M | $3.2M | $3.4M |
| Equity | $8.2M | $7.9M | $8.2M | $8.6M | $9.3M | $9.6M | $10.0M | $10.2M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-672000 | $-501000 | $-623000 | $1.3M | $322000 | $994000 | $99000 | $230000 |